Higuchi Masahiro, Ushiba Kae, Kawaguchi Masami
Department of Chemistry for Materials, Graduate School of Engineering, Mie University, 1577 Kurimanakayama-Cho, Tsu, Mie 514-8507, Japan.
J Colloid Interface Sci. 2007 Apr 15;308(2):356-63. doi: 10.1016/j.jcis.2006.12.069. Epub 2007 Jan 31.
Gold nanoparticles having peptide chains on the surfaces have been prepared yb ring-opening polymerization of gamma-methyl L-glutamate N-carboxyanhydride with fixed amino groups on the nanoparticle surface as an initiator. The number of peptide chains on the surface was adjusted to ca. 2 molecules per gold nanoparticle by controlling the number of fixed amino groups on the surface. The peptide chains on the surface were partially saponified to obtain poly(gamma-methyl L-glutamate-co-L-glutamic acid) with 28 mol% of glutamic acid residues. The number-average molecular weight of the peptide was 73,000. We described structural control of the peptide-coated gold nanoparticle assembly by conformational transition of the surface peptides. In deionized water, the peptide chains on the nanoparticle took a random coil conformation, and the individual nanoparticles existed in dispersed globular species. On the other hand, the peptide chains on the nanoparticle took an alpha-helical conformation in trifluoroethanol. Under this condition, the alpha-helical peptide chains on distinct gold nanoparticles connected the nanoparticles to form a fibril assembly owing to the dipole-dipole interaction between the surface peptide chains. The morphology of the peptide-coated gold nanoparticle assembly could be controlled by the conformational transition of surface peptides, which was attended by solution composition changes.
通过以纳米颗粒表面的固定氨基为引发剂,使γ-甲基-L-谷氨酸N-羧基酸酐开环聚合,制备了表面带有肽链的金纳米颗粒。通过控制表面固定氨基的数量,将表面肽链的数量调整为每个金纳米颗粒约2个分子。表面的肽链部分皂化,得到谷氨酸残基含量为28 mol%的聚(γ-甲基-L-谷氨酸-co-L-谷氨酸)。肽的数均分子量为73,000。我们描述了通过表面肽的构象转变对肽包覆金纳米颗粒组装体的结构控制。在去离子水中,纳米颗粒上的肽链呈无规卷曲构象,单个纳米颗粒以分散的球状形式存在。另一方面,纳米颗粒上的肽链在三氟乙醇中呈α-螺旋构象。在这种条件下,由于表面肽链之间的偶极-偶极相互作用,不同金纳米颗粒上的α-螺旋肽链将纳米颗粒连接起来形成纤维状组装体。肽包覆金纳米颗粒组装体的形态可以通过表面肽的构象转变来控制,而构象转变伴随着溶液组成的变化。